Opening book details…
About this Medicine article
P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON-HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS-3 TRIAL by P. L. Zinzani; M. Özcan; K. Sapunarova; W. Jurczak; A. Hamed; K. Bouabdallah; G. Saydam; K. Geissler; Á. Szomor; M. Lazaroiu; A. Salar; A. Tempescul; M. Nalcaci; L. Gercheva; M. Egyed; P. Panayiotidis; L. Mongay Soler; A. Cao; C. Phelps; B. H Childs; M. J Matasar is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- P. L. Zinzani; M. Özcan; K. Sapunarova; W. Jurczak; A. Hamed; K. Bouabdallah; G. Saydam; K. Geissler; Á. Szomor; M. Lazaroiu; A. Salar; A. Tempescul; M. Nalcaci; L. Gercheva; M. Egyed; P. Panayiotidis; L. Mongay Soler; A. Cao; C. Phelps; B. H Childs; M. J Matasar
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Published
- 2022
- Language
- EN
- Field
- Medicine (Health Sciences)